Wall Street analysts expect Caleres (NYSE:CAL) to post earnings of $0.48 per share for the current quarter, according to Zacks. Two analysts have made estimates for Caleres’ earnings, with estimates ranging from $0.44 to $0.52. Caleres posted earnings per share of $0.40 in the same quarter last year, which suggests a positive year-over-year growth rate of 20%. The firm is scheduled to report its next quarterly earnings results on Thursday, May 24th.
According to Zacks, analysts expect that Caleres will report full year earnings of $2.48 per share for the current year, with EPS estimates ranging from $2.46 to $2.50. For the next financial year, analysts expect that the firm will report earnings of $2.70 per share, with EPS estimates ranging from $2.65 to $2.75. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side analysts that cover Caleres.
Caleres (NYSE:CAL) last announced its earnings results on Tuesday, March 13th. The textile maker reported $0.48 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.44 by $0.04. The business had revenue of $702.50 million for the quarter, compared to analyst estimates of $695.61 million. Caleres had a net margin of 3.13% and a return on equity of 14.01%. The company’s revenue for the quarter was up 9.9% compared to the same quarter last year. During the same period last year, the firm posted $0.33 earnings per share.
A number of equities analysts have recently issued reports on CAL shares. UBS lowered shares of Caleres from a “positive” rating to a “neutral” rating in a research report on Tuesday, January 23rd. Susquehanna Bancshares restated a “neutral” rating and set a $33.00 target price (up from $32.00) on shares of Caleres in a research report on Tuesday, January 23rd. ValuEngine lowered shares of Caleres from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Zacks Investment Research upgraded shares of Caleres from a “hold” rating to a “buy” rating and set a $33.00 target price on the stock in a research report on Friday, February 2nd. Finally, Wedbush restated an “outperform” rating and set a $35.00 target price on shares of Caleres in a research report on Wednesday, March 14th. One analyst has rated the stock with a sell rating, three have issued a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. Caleres presently has an average rating of “Buy” and an average price target of $35.20.
In related news, insider Daniel R. Freidman sold 2,000 shares of the stock in a transaction on Monday, March 19th. The stock was sold at an average price of $31.81, for a total transaction of $63,620.00. Following the completion of the sale, the insider now directly owns 91,733 shares of the company’s stock, valued at $2,918,026.73. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Richard M. Ausick sold 3,110 shares of the stock in a transaction on Monday, April 9th. The stock was sold at an average price of $34.78, for a total value of $108,165.80. Following the sale, the insider now directly owns 69,834 shares of the company’s stock, valued at $2,428,826.52. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 49,089 shares of company stock valued at $1,641,878. Corporate insiders own 6.20% of the company’s stock.
Several hedge funds and other institutional investors have recently modified their holdings of CAL. Mosaic Family Wealth LLC acquired a new stake in shares of Caleres during the fourth quarter worth $140,000. Xact Kapitalforvaltning AB acquired a new stake in shares of Caleres during the fourth quarter worth $201,000. Amalgamated Bank acquired a new stake in shares of Caleres during the fourth quarter worth $204,000. Quantitative Systematic Strategies LLC acquired a new stake in shares of Caleres during the fourth quarter worth $234,000. Finally, Cubist Systematic Strategies LLC lifted its holdings in shares of Caleres by 440.0% during the third quarter. Cubist Systematic Strategies LLC now owns 10,362 shares of the textile maker’s stock worth $316,000 after purchasing an additional 8,443 shares during the period. 89.68% of the stock is owned by hedge funds and other institutional investors.
Shares of CAL traded down $0.26 during mid-day trading on Thursday, reaching $33.74. 210,978 shares of the company’s stock were exchanged, compared to its average volume of 330,239. The company has a current ratio of 1.97, a quick ratio of 0.64 and a debt-to-equity ratio of 0.27. The firm has a market cap of $1,460.86, a PE ratio of 15.62, a price-to-earnings-growth ratio of 1.25 and a beta of 0.94. Caleres has a 52-week low of $22.39 and a 52-week high of $36.00.
The business also recently declared a quarterly dividend, which was paid on Monday, April 2nd. Investors of record on Monday, March 19th were issued a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.83%. The ex-dividend date was Friday, March 16th. Caleres’s dividend payout ratio is presently 12.96%.
ILLEGAL ACTIVITY WARNING: “Zacks: Analysts Expect Caleres (CAL) Will Post Earnings of $0.48 Per Share” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/04/19/zacks-analysts-expect-caleres-cal-will-post-earnings-of-0-48-per-share.html.
Caleres, Inc, a footwear company, retails and wholesales footwear. The company operates through Famous Footwear and Brand Portfolio segments. It offers licensed, branded, and private-label casual, dress, and athletic footwear products to women, men, and children. The company operates retail shoe stores primarily under the Famous Footwear and Naturalizer names, which offer brand-name athletic, casual, and dress shoes, including company-owned and licensed brands, such as LifeStride, Dr.
Get a free copy of the Zacks research report on Caleres (CAL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Caleres Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Caleres and related companies with MarketBeat.com's FREE daily email newsletter.